Study S001680

Semaglutide for Smoking Cessation in Patients With Diabetes: A Pilot Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07059377
Acronym: GLP1-SC
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 100
Start: 2026-02-13
Primary completion: 2026-12
Lead sponsor: Ottawa Heart Institute Research Corporation
Conditions: Diabetes Mellitus, Type 2; Nicotine Addiction; Tobacco Dependence
Interventions: DRUG:Semaglutide; DRUG:Nicotine replacement
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Project success [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.